Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![StckMasterFlash Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::235990471.png) Stock Master Flash [@StckMasterFlash](/creator/twitter/StckMasterFlash) on x 2902 followers
Created: 2025-07-23 21:04:45 UTC

In a market projected to grow to nearly half a billion dollars by 2035, @thiogenesis is dosing patients in its EU Phase X trial for TTI‑0102, targeting the underlying antioxidant deficiencies in MELAS. 
 
Interim efficacy readout expected this fall.

More Info🔽 $TTI.v $TTIPF

Source:

![](https://pbs.twimg.com/media/GwkjU42XMAMT4ua.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948127165847138686/c:line.svg)

**Related Topics**
[$tti](/topic/$tti)
[$ttipf](/topic/$ttipf)
[$ttiv](/topic/$ttiv)
[more info](/topic/more-info)

[Post Link](https://x.com/StckMasterFlash/status/1948127165847138686)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

StckMasterFlash Avatar Stock Master Flash @StckMasterFlash on x 2902 followers Created: 2025-07-23 21:04:45 UTC

In a market projected to grow to nearly half a billion dollars by 2035, @thiogenesis is dosing patients in its EU Phase X trial for TTI‑0102, targeting the underlying antioxidant deficiencies in MELAS.

Interim efficacy readout expected this fall.

More Info🔽 $TTI.v $TTIPF

Source:

XX engagements

Engagements Line Chart

Related Topics $tti $ttipf $ttiv more info

Post Link

post/tweet::1948127165847138686
/post/tweet::1948127165847138686